Oertel Michael, Menthena Anuradha, Chen Yuan-Qing, Shafritz David A
Marion Bessin Liver Research Center, Albert Einstein College of Medicine of Yeshiva University, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Stem Cells. 2006 Oct;24(10):2244-51. doi: 10.1634/stemcells.2006-0141. Epub 2006 Jun 15.
We have previously achieved a high level of long-term liver replacement by transplanting freshly isolated embryonic day (ED) 14 rat fetal liver stem/progenitor cells (FLSPCs). However, for most clinical applications, it will be necessary to use cryopreserved cells that can effectively repopulate the host organ. In the present study, we report the growth and gene expression properties in culture of rat FLSPCs cryopreserved for up to 20 months and the ability of cryopreserved FLSPCs to repopulate the normal adult rat liver. After thawing and placement in culture, cryopreserved FLSPCs exhibited a high proliferation rate: 49.7% Ki-67-positive on day 1 and 34.7% Ki-67-positive on day 5. The majority of cells were also positive for both alpha-fetoprotein and cytokeratin-19 (potentially bipotent) on day 5. More than 80% of cultured cells expressed albumin, the asialoglycoprotein receptor, and UDP-glucuronosyltransferase (unique hepatocyte-specific functions). Expression of glucose-6-phosphatase, carbamyl phosphate synthetase 1, hepatocyte nuclear factor 4alpha, tyrosine aminotransferase, and oncostatin M receptor mRNAs was initially negative, but all were expressed on day 5 in culture. After transplantation into the normal adult rat liver, cryopreserved FLSPCs proliferated continuously, regenerated both hepatocytes and bile ducts, and produced up to 15.1% (mean, 12.0% +/- 2.0%) replacement of total liver mass at 6 months after cell transplantation. These results were obtained in a normal liver background under nonselective conditions. This study is the first to show a high level of long-term liver replacement with cryopreserved fetal liver cells, an essential requirement for future clinical applications.
我们之前通过移植新鲜分离的胚胎第14天(ED14)大鼠胎肝干细胞/祖细胞(FLSPCs)实现了高水平的长期肝脏替代。然而,对于大多数临床应用而言,使用能够有效重新填充宿主器官的冷冻保存细胞将是必要的。在本研究中,我们报告了冷冻保存长达20个月的大鼠FLSPCs在培养中的生长和基因表达特性,以及冷冻保存的FLSPCs重新填充正常成年大鼠肝脏的能力。解冻并置于培养后,冷冻保存的FLSPCs表现出高增殖率:第1天Ki-67阳性率为49.7%,第5天为34.7%。第5天,大多数细胞甲胎蛋白和细胞角蛋白-19(可能具有双能性)也呈阳性。超过80%的培养细胞表达白蛋白、去唾液酸糖蛋白受体和UDP-葡萄糖醛酸基转移酶(独特的肝细胞特异性功能)。葡萄糖-6-磷酸酶、氨甲酰磷酸合成酶1、肝细胞核因子4α、酪氨酸转氨酶和抑瘤素M受体mRNA的表达最初为阴性,但在培养第5天时均有表达。将冷冻保存的FLSPCs移植到正常成年大鼠肝脏后,其持续增殖,再生肝细胞和胆管,在细胞移植后6个月时产生高达15.1%(平均12.0%±2.0%)的肝脏总质量替代。这些结果是在非选择性条件下的正常肝脏背景中获得的。本研究首次表明冷冻保存的胎肝细胞可实现高水平的长期肝脏替代,这是未来临床应用的一项基本要求。